U.S. Online Retail and Ecommerce Stock News

Interactive Brokers Group (IBKR) recently attracted renewed attention after receiving a Zacks Rank #2 (Buy) upgrade, reflecting higher earnings estimates over the past 3 months and analysts indicating stronger underlying business trends. See our latest analysis for Interactive Brokers Group. The recent upgrade appears against a backdrop of firm share price momentum, with a 30 day share price return of 13.49% and a 1 year total shareholder return of 54.38%. This points to interest that extends...

AGNC Investment Corp. recently announced that its Board re-elected housing economist Dr. Morris Davis as an independent director effective January 12, 2026, and confirmed a US$0.12 per-share cash dividend for January 2026, payable on February 10, 2026 to stockholders of record on January 30, 2026. Dr. Davis’s return to the Board, following his tenure as Chief Housing Economist on the President’s Council of Economic Advisors, brings specialized housing and mortgage market expertise back into...

Earlier in January 2026, Monte Rosa Therapeutics completed a roughly US$300.00 million follow-on equity offering, including 11,125,000 common shares at US$24 each and 1,375,000 pre-funded warrants, shortly after releasing positive interim Phase 1 data for its NEK7-directed degrader MRT-8102 in inflammatory conditions. The Phase 1 results, showing deep NEK7 degradation alongside broad reductions in inflammatory markers such as hsCRP and IL-6 with a favorable safety profile in higher...

Concrete Pumping Holdings (BBCP) just wrapped up FY 2025 with fourth quarter revenue of US$108.8 million and basic EPS of US$0.10, alongside net income of US$4.9 million, setting the tone for how the year closed out. The company has seen quarterly revenue move from US$111.5 million and EPS of US$0.17 in Q4 FY 2024 to US$108.8 million and EPS of US$0.10 in Q4 FY 2025, while trailing twelve month net profit margins sit at 1.2% compared with 3.4% a year earlier, so investors are weighing modest...

NextEra Energy has previously announced that it will release its fourth-quarter and full-year 2025 financial results before the NYSE opens on January 27, 2026, followed by a webcast where senior management will review the numbers and outlook with investors. This scheduled earnings release, coming amid steady analyst optimism and the company’s positioning in clean power, is sharpening focus on how its fundamentals align with broader expectations for stable growth in the utility and renewables...

Nuvalent (NUVL) is back in focus after the FDA accepted its New Drug Application for zidesamtinib and set a PDUFA action date of September 18, 2026, which is anchoring expectations around its first potential commercial launch. See our latest analysis for Nuvalent. The NDA news has arrived after a strong run, with Nuvalent’s share price at US$107.84 and a 90 day share price return of 16.56%, while the 1 year total shareholder return of 41.91% and 3 year total shareholder return of around 3.3x...

VSE (VSEC) has drawn fresh attention after a strong recent share move, with the stock up about 23% over the past month and 34% over the past 3 months based on provided returns. See our latest analysis for VSE. At a latest share price of $208.83, VSE has seen a 23.29% 30 day share price return and a 33.61% 90 day share price return, while its 1 year total shareholder return of 108.67% and 5 year total shareholder return of about 4.4x indicate strong momentum rather than a short term swing in...

PACCAR (PCAR) is back in focus after recent trading left the shares around $119, prompting investors to reassess how its truck manufacturing, parts distribution, and financial services segments line up with current return and valuation metrics. See our latest analysis for PACCAR. While the 1 day share price return shows a small pullback, the 90 day share price return of 25.05% and 1 year total shareholder return of 11.39% suggest momentum has been building over both shorter and longer...

TechnipFMC: recent performance snapshot TechnipFMC (FTI) has drawn fresh attention after a strong stretch of share performance, with returns of 3.6% over the past day, 6.2% in the past week, and 13.1% over the past month. See our latest analysis for TechnipFMC. That near term strength builds on a much longer run, with the share price delivering a 46.3% 90 day share price return and a 1 year total shareholder return of 62.0%, suggesting momentum has been building rather than fading. If...

Recent attention on Medtronic (MDT) has centered on two fresh catalysts: a partnership with Precision Neuroscience to link brain activity data with surgical navigation tools, and FDA 510(k) clearance for its connected MiniMed Go diabetes system. See our latest analysis for Medtronic. Those neurosurgery and diabetes updates come as Medtronic’s share price sits at US$98.74, with a 3.9% 90 day share price return and a 19.3% 1 year total shareholder return. This suggests momentum has been...

Wave Life Sciences recently outlined its 2026 priorities at the 44th Annual J.P. Morgan Healthcare Conference, emphasizing accelerated development of obesity candidate WVE-007, expansion of its RNA editing pipeline, and upcoming trials and regulatory filings across obesity, liver disease, and genetic disorders. A key highlight for investors was early WVE-007 data suggesting fat loss on par with GLP-1 therapies while preserving muscle, alongside planned multidose and add-on incretin trials...

Lindsay (LNN) shares have been reacting to the company’s first quarter earnings, which showed sales of US$155.82 million and net income of US$16.52 million, both below the comparable period last year. See our latest analysis for Lindsay. The recent first quarter results, along with a reaffirmed quarterly dividend and a new Chief Accounting Officer, come as Lindsay’s share price sits at US$124.72. The 7 day share price return is 5.21%, while the 1 year total shareholder return shows a 3.43%...

Understanding what is moving SiriusPoint shares SiriusPoint (SPNT) has stayed on investors’ radars after mixed recent returns, with a gain over the past 3 months but declines over the past month and year to date prompting closer attention. See our latest analysis for SiriusPoint. The latest share price of $20.17 sits alongside a 30 day share price return of a 9.63% decline and a 90 day share price return of a 13.63% gain. The 1 year total shareholder return of 36.38% and 3 year total...

Dillard's stock performance snapshot Dillard's (DDS) has drawn investor interest after a mixed return profile, with a 1 day decline of 7.4% and a month pullback of 4.4%, alongside a 1 year total return of 49.7%. See our latest analysis for Dillard's. The recent 7.4% one day share price decline and softer 1 month share price return sit against a much stronger backdrop, with the 1 year total shareholder return close to 50% and the 5 year total shareholder return above 10x. If Dillard's recent...

Interest in Philip Morris International (PM) has picked up as investors react to recent fund commentary on its reduced risk products and look ahead to the company’s upcoming Q4 2025 earnings and dividend story. See our latest analysis for Philip Morris International. The stronger interest in reduced risk products and the upcoming Q4 2025 earnings update has coincided with a clear pickup in momentum, with a 1 month share price return of 8% and a 1 year total shareholder return of 49.46% from a...

Context for D-Wave Quantum’s recent stock moves D-Wave Quantum (QBTS) has drawn investor attention after a recent stretch of mixed returns, with a gain over the month but weaker performance over the past 3 months. This has prompted closer scrutiny of its fundamentals. The company operates in quantum computing systems and services, and recent price swings are being weighed against its current revenue base, ongoing losses, and growth metrics as investors reassess risk and potential reward. See...

Wondering whether Amazon.com’s share price still makes sense after its long run as a market favorite? This article walks you through what that current price could imply about value. The stock last closed at US$236.65, with a 3.9% decline over 7 days, a 6.3% gain over 30 days, and returns of 4.5% year to date, 7.2% over 1 year, 152.6% over 3 years, and 43.1% over 5 years. Recent headlines around Amazon.com have focused on its ongoing expansion across e commerce and cloud services, as well as...

Li Auto Inc. reported past operating results for December and full-year 2025, disclosing deliveries of 44,246 vehicles for the month, 109,194 for the quarter, and about 1.54 million for the year. The scale of these deliveries underscores how central monthly and annual volume data have become for assessing Li Auto’s execution and demand profile. We’ll now examine how Li Auto’s approximately 1.54 million full-year 2025 deliveries may influence the company’s existing investment narrative. The...

Earlier this month, Realty Income announced its 667th consecutive monthly dividend of US$0.2700 per share, payable on February 13, 2026 to shareholders of record on January 30, 2026. The company also unveiled a long-term partnership with GIC, including a US$1.50 billions logistics joint venture and its first industrial investment in Mexico via a roughly US$200 million build-to-suit portfolio. We’ll now examine how the GIC logistics joint venture and Mexico expansion could influence Realty...

If you are wondering whether KBR's current share price reflects its true worth, you are not alone. Many investors are asking the same question. The stock last closed at US$44.02, with returns of 4.2% over 7 days, 2.2% over 30 days, 8.7% year to date, a 25.1% decline over 1 year, a 8.5% decline over 3 years, and a 47.7% gain over 5 years. Recent news around KBR has highlighted ongoing interest in its role within the commercial services and engineering space, keeping attention on how its...

Earlier this month, Kiniksa Pharmaceuticals International presented at the 44th Annual J.P. Morgan Healthcare Conference and later reported that ARCALYST’s adoption as a second-line treatment for recurrent pericarditis underpinned its projection of US$900 million to US$920 million in net product revenue for 2026, supported by a cash balance of US$414.1 million and no debt. The company also highlighted pipeline progress, including the ongoing Phase 2/3 trial for KPL-387 with data expected in...

Arcellx (ACLX) is back in focus after reporting Phase 2 data for its anitocabtagene autoleucel therapy in relapsed or refractory multiple myeloma, which showed a 96% overall response rate and a 74% complete response rate. See our latest analysis for Arcellx. The latest anitocabtagene autoleucel update comes after a mixed stretch for Arcellx, with a 7 day share price return of 7.46% and a 90 day share price return decline of 21.37%, while the 3 year total shareholder return of 119.69% points...

Melco Resorts & Entertainment previously announced that, effective April 1, eligible non-management employees in Macau would receive pay rises ranging from 2% to 6.3%, with full-time staff earning up to MOP$16,000 per month getting a fixed increment and higher earners receiving a 2% increase. The move highlights management’s focus on employee retention and workforce stability in Macau’s competitive hospitality market, which can be an important consideration for long-term operational...

Event context and recent return snapshot Innovex International (INVX) has attracted fresh attention after recent trading moves, with the stock showing a 1 day return of about a 1% decline, alongside gains over the past week, month, and past 3 months. See our latest analysis for Innovex International. That short term pullback sits against a stronger backdrop, with a 90 day share price return of 36.71% and a 1 year total shareholder return of 40.27%. This points to momentum building rather than...